Kursinformationen zu Manulife Global Fund - Healthcare Fund I3
- NAV in CHF
- 1.34
- Tagesveränderung relativ
- -0.16%
- Tagesveränderung absolut
- -0.00
- NAV Vortag
- 1.34
- Letzter Handel
- 29.09.2026
- Ausgabekommissionen
- +0.00%
- Verwaltungsgebühr
- -
- OGC
- 0.00 %
- Monatsbericht
- -
- Halbjahresbericht
- -
- Jahresbericht
- -
- Vollständiger Fondsprospekt
- -
- Gesetzl. Publikationen
- -
Healthcare Fund aims to provide medium to long term capital growth for those who hold a long term investment view and who are prepared to accept significant fluctuations in the value of their investments in order to achieve long term returns. It is intended that the investments will be made on a diversified basis. The underlying investment portfolio will mainly consist of equity and equity related securities of companies in health care and related industries globally and which are listed on any stock exchange. The Sub-Fund may invest in companies which derive a significant portion of their earnings from medical and pharmaceutical products and services. The remaining assets of the Sub-Fund may include bonds and deposits. The Healthcare Fund will invest at least 80% of its net assets in equity and equity related securities of health sciences companies. These companies will derive more than half of their revenues from health care-related business activities or commit more than half of their assets to these activities. Such equity and equity related securities include common stocks, preferred stocks and depositary receipts.
| Zeitraum | Performance | Volatilität | Sharpe Ratio | Bester Monat | Schlecht. Monat | Max Verlust |
|---|---|---|---|---|---|---|
| YTD | +5.44% | +15.46% | +0.31% | +4.93% | -7.23% | -10.27% |
| 6 Monate | +9.91% | +15.55% | +1.17% | +4.93% | -7.23% | -5.75% |
| 1 Jahr | +23.69% | +14.82% | +1.42% | +10.27% | -7.23% | -10.27% |
| 3 Jahre | +37.75% | +14.13% | +0.61% | +10.27% | -7.23% | -18.50% |
| 5 Jahre | +48.98% | +14.59% | +0.39% | +10.27% | -7.55% | -18.50% |
- ISIN
- LU1220955923
- Valor
- 28554812
- Währung
- USD
- Fondstyp
- Aktienfonds
- Ertragsart
- ausschüttend
- Anlageschwerpunkt
- Branche Gesundheit/Pharma
- Anlageregion
- weltweit
- Domizil
- -
- Vertriebszulassung
- Luxemburg
- Auflagedatum
- 27.06.2008
- Fondsvolumen
- 403'505'539.18
- Geschäftsjahresbeginn
- 01.07.2026
- Benchmark
- -
- Fondsgesellschaft
- Manulife IM
- Eli Lilly and Company
- 9.26 %
- Johnson & Johnson
- 6.64 %
- AstraZeneca PLC
- 6.22 %
- AbbVie, Inc.
- 5.62 %
- Amgen Inc.
- 4.72 %
- Medtronic Plc
- 4.71 %
- Stryker Corporation
- 4.27 %
- McKesson Corporation
- 4.26 %
- Roche Holding Ltd Dividend Right Cert.
- 3.85 %
- Thermo Fisher Scientific Inc.
- 3.12 %
- Pharmazeutika Produktion
- 38.70 %
- Gesundheitswesen
- 20.70 %
- Pharmazeutika/Biotechnologie
- 20.22 %
- Medizinische Produkte/Instrumente
- 18.76 %
- Barmittel und sonst. VM
- 1.62 %